Get the Stockscreener App
169.86
5.53%
8.90
After Hours:
169.86
Icon Plc stock is traded at $169.86, with a volume of 1.44M.
It is up +5.53% in the last 24 hours and up +49.20% over the past month.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
See More
Previous Close:
$160.96
Open:
$158.593
24h Volume:
1.44M
Relative Volume:
1.23
Market Cap:
$13.01B
Revenue:
$8.24B
Net Income/Loss:
$222.68M
P/E Ratio:
62.44
EPS:
2.7203
Net Cash Flow:
$888.99M
1W Performance:
+16.34%
1M Performance:
+49.20%
6M Performance:
-7.10%
1Y Performance:
+15.75%
1-Day Range:
$158.59
$170.51
1-Week Range:
$138.84
$170.51
52-Week Range:
$66.57
$211.00
Icon Plc Stock (ICLR) Company Profile
Compare ICLR vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
169.86 | 12.33B | 8.24B | 222.68M | 888.99M | 2.7203 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-26 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-23-26 | Upgrade | Jefferies | Hold → Buy |
| Feb-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-17-26 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Feb-12-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-12-26 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-26 | Downgrade | Truist | Buy → Hold |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Sep-09-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-03-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Aug-21-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-24-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-29-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-21-25 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Neutral |
| Sep-18-24 | Initiated | Leerink Partners | Outperform |
| Jun-06-24 | Initiated | Goldman | Buy |
| Dec-15-23 | Initiated | Truist | Buy |
| Sep-13-23 | Initiated | TD Cowen | Outperform |
| Jan-17-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-13-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-09-22 | Upgrade | BofA Securities | Neutral → Buy |
| Sep-07-22 | Initiated | UBS | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-12-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-21 | Initiated | Citigroup | Neutral |
| Apr-13-21 | Resumed | BofA Securities | Neutral |
| Apr-01-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-08-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-03-21 | Initiated | Barclays | Equal Weight |
| Mar-01-21 | Upgrade | UBS | Neutral → Buy |
| Feb-26-21 | Upgrade | Truist | Hold → Buy |
| Jul-24-20 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-20-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-02-20 | Initiated | Deutsche Bank | Hold |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Sep-23-19 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jul-26-19 | Upgrade | UBS | Sell → Neutral |
| Jan-25-19 | Upgrade | Mizuho | Neutral → Buy |
| Oct-26-18 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-09-18 | Initiated | UBS | Sell |
| Apr-03-18 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-15-18 | Reiterated | Mizuho | Neutral |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
| Oct-27-17 | Reiterated | Barclays | Equal Weight |
| Sep-11-17 | Initiated | BofA/Merrill | Buy |
| Jul-31-17 | Upgrade | SunTrust | Hold → Buy |
| Jul-27-17 | Reiterated | Mizuho | Neutral |
| Jun-29-17 | Upgrade | Jefferies | Hold → Buy |
View All
Icon Plc Stock (ICLR) Latest News
Icon PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Shs Actuals & Estimates (BMFBOVESPA:ICLR34) - TradingView
ICON (ICLR) Slides as Investors Stay Cautious Ahead of Delayed Results Tied to Accounting Review - Moomoo
Icon PLC (ICLR) Shares Surge 5.5% -- What GF Score of 87 Tells I - GuruFocus
What Just Happened at ICON (ICLR) and Why Did Shares Soar - Kavout | AI
Accounting restatement, big impairments and AGM plans at ICON plc (NASDAQ: ICLR) - Stock Titan
Enterprise value to EBITDA forward of ICON plc – NASDAQ:ICLR - TradingView
ICON Plc Actuals & Estimates (NASDAQ:ICLR) - TradingView
Enterprise value to revenue forward of ICON plc – NASDAQ:ICLR - TradingView
ICON Plc Actuals & Estimates (FWB:IJF) - TradingView
Price to book forward of ICON plc – NASDAQ:ICLR - TradingView
Mizuho raises ICON stock price target to $190 on bookings strength By Investing.com - Investing.com Australia
Price to earnings forward of ICON plc – NASDAQ:ICLR - TradingView
IJF Forecast — Price Target — Prediction for 2027 - TradingView
ICON PLC : BMO Raises Target Price to $187 Fr - Moomoo
RBC Upgrades ICON to Outperform From Sector Perform, Raises Price Target to $185 From $126 - Moomoo
Icon PLC (ICLR) Q1 2026 Earnings Call Highlights: Strong Bookings and Strategic Expansions Amid Margin Pressures - GuruFocus
RBC Capital upgrades ICON stock on sustained bookings strength By Investing.com - Investing.com Australia
ICON plc Selects Microsoft (MSFT) As Preferred Technology Partner - Insider Monkey
Icon Q1 2026 Earnings Call Transcript - MarketBeat
ICON PLC (ICLR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ICON PLC : JP MORGAN RAISES TARGET PRICE TO $155 FROM $130 - Moomoo
ICON plc (ICLR) Reports Strong Q1 2026 Performance with $3.3B in Gross Bookings - GuruFocus
BofA raises ICON stock price target to $150 on earnings beat - Investing.com UK
Leerink raises ICON stock price target to $170 on bookings strength - Investing.com South Africa
Leerink raises ICON stock price target to $170 on bookings strength By Investing.com - Investing.com Australia
BofA raises ICON stock price target to $150 on earnings beat By Investing.com - Investing.com India
ICON plc Stock 12‑Month Price Target Raised to $161.33, Implies 13% Upside - TradingView
Why Icon Stock Crushed it on Wednesday - Yahoo Finance
Why Icon Stock Crushed it on Wednesday - The Motley Fool
U.S. Indexes Ended Wednesday Mixed As Icon PLC Led, Cerebras Systems Lagged - Barron's
ICLR Stock Pops As ICON plc Beats Earnings And Doubles Down On AI - StocksToTrade
ICLR Stock Pops As ICON plc Bets Big On AI With Microsoft - StocksToTrade
Earnings call transcript: ICON plc Q1 2026 revenue beats as shares jump - Investing.com South Africa
Icon Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Truist Financial Maintains Icon PLC(ICLR.US) With Hold Rating - Moomoo
Q1 2026 ICON PLC Earnings Call Transcript - GuruFocus
Barclays Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $160 - Moomoo
Key facts: ICON Q1 Revenue, EPS Beat; Net Debt $2.6B, Guidance Held - TradingView
Form 6K ICON PLC For: 23 June By Investing.com - Investing.com South Africa
Icon PLC: Q1 Earnings Snapshot - AOL.com
Form 6K ICON PLC For: 23 June - Investing.com UK
ICON Q1 OPERATING INCOME USD 173.734 MILLION VS. IBES ESTIMATE USD 265.5 MILLION - Moomoo
Icon Backs 2026 Adj EPS $10-Adj EPS $11 >ICLR - Moomoo
Icon Backs 2026 Rev $7.85B-$8.15B >ICLR - Moomoo
[6-K] ICON PLC Current Report (Foreign Issuer) | ICLR SEC FilingForm 6-K - Stock Titan
Earnings Flash (ICLR) ICON Posts Fiscal Q1 Revenue of $2.03B, Vs. FactSet Est of $2B - Moomoo
ICON plc (NASDAQ: ICLR) Q1 2026 results show weaker EPS but guidance reaffirmed - Stock Titan
ICON Reports First Quarter 2026 Results - Business Wire
Freshers Life Science Internship at ICON 2026 – Opportunity for Students & Graduates - BioTecNika
Icon PLC (ICLR) Shares Fall 3.6% -- What GF Score of 83 Tells In - GuruFocus
ICON (ICLR) Partners with Microsoft to Enhance AI Capabilities - GuruFocus
Icon Plc Stock (ICLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.76%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):